Literature DB >> 25621538

Executive functioning and risk for Alzheimer's disease in the cognitively intact: Family history predicts Wisconsin Card Sorting Test performance.

Kathleen E Hazlett1, Christina M Figueroa1, Kristy A Nielson1.   

Abstract

OBJECTIVE: Alzheimer's disease (AD) research typically focuses on memory. However, executive functioning (EF) deficits are also common among AD patients; these deficits are associated with decreased functioning in activities of daily living, an important criterion in diagnosing AD. A classic test of EF ability, the Wisconsin Card Sort Test (WCST), has demonstrated sensitivity to differentiating individuals with AD from healthy controls, discriminating AD groups based on disease severity, and distinguishing AD from other types of dementia. Such sensitivity to AD raises the possibility that the WCST is also sensitive to very early, preclinical differences between those who have heightened risk for AD and those with lower risks.
METHOD: The current study, therefore, examined WCST performance in healthy, cognitively intact older adults with a first-degree (i.e., sibling or parent) family history (FH) of AD (n = 18) and those with no such FH of AD (n = 24).
RESULTS: Results revealed significant group differences for Categories Achieved, Percent Conceptual Level Responses, Total Errors, Perseverative Errors, and Non-Perseverative Errors, with the FH+ group consistently exhibiting poorer performance. Moreover, hierarchical regression analyses indicated that after accounting for age, sex, and education, FH significantly predicted all 5 of these variables.
CONCLUSIONS: These results speak to the potential role of EF in bolstering the current understanding of early cognitive markers of future decline. Furthering what is known about the relationship between AD and nonmemory specific domains of cognition such as executive functioning may allow for better prediction of cognitive decline and potential progression to AD. (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Year:  2015        PMID: 25621538     DOI: 10.1037/neu0000181

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  7 in total

1.  One executive function never comes alone: monitoring and its relation to working memory, reasoning, and different executive functions.

Authors:  Bettina Gathmann; Matthias Brand; Johannes Schiebener
Journal:  Cogn Process       Date:  2016-07-09

Review 2.  Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine.

Authors:  Aseel Eid; Isha Mhatre; Jason R Richardson
Journal:  Pharmacol Ther       Date:  2019-03-12       Impact factor: 12.310

Review 3.  Cognitive Functioning of Unaffected First-degree Relatives of Individuals With Late-onset Alzheimer's Disease: A Systematic Literature Review and Meta-analysis.

Authors:  Ari Alex Ramos; Noelia Galiano-Castillo; Liana Machado
Journal:  Neuropsychol Rev       Date:  2022-09-03       Impact factor: 6.940

Review 4.  Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration.

Authors:  Marisa E Marraccini; Lisa L Weyandt; Joseph S Rossi; Bergljot Gyda Gudmundsdottir
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

5.  A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.

Authors:  Edmarie Guzmán-Vélez; Sehily Jaimes; Daniel C Aguirre-Acevedo; Daniel J Norton; Kathryn V Papp; Rebecca Amariglio; Dorene Rentz; Ana Baena; Eliana Henao; Victoria Tirado; Claudia Muñoz; Margarita Giraldo; Reisa A Sperling; Francisco Lopera; Yakeel T Quiroz
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.

Authors:  Whitney Wharton; Felicia C Goldstein; Malú G Tansey; Alexandra L Brown; Sonum D Tharwani; Danielle D Verble; Amarallys Cintron; Patrick G Kehoe
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Cognitive and biological effects of citrus phytochemicals in subjective cognitive decline: a 36-week, randomized, placebo-controlled trial.

Authors:  Samantha Galluzzi; Roberta Zanardini; Clarissa Ferrari; Sara Gipponi; Ilaria Passeggia; Michela Rampini; Giovanni Sgrò; Salvatore Genovese; Serena Fiorito; Lucia Palumbo; Michela Pievani; Giovanni B Frisoni; Francesco Epifano
Journal:  Nutr J       Date:  2022-10-17       Impact factor: 4.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.